Advanz Pharma

Advanz Pharma is a global pharmaceutical company dedicated to meeting the needs of patients and healthcare providers worldwide by offering more high-quality, mature niche-market drugs. The company is committed to advancing its leading candidate drug, ADX-914, with plans to initiate the first phase of ADX-914 studies by the end of 2020 if all goes well.